Transgenic alfalfa that accumulates piceid (trans-resveratrol-3-O-β-D- glucopyranoside) requires the presence of β-glucosidase to inhibit the formation of aberrant crypt foci in the colon of CF-1 mice

Nutrition and Cancer

Volumn 58, Issue 1, 2007, Pages 66-74

  Kineman, Brian D ^a   Au, Angela ^a   Paiva, Nancy L ^b,c   Kaiser, Mark S ^d   Brummer, E Charles ^a   Birt, Diane F ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b PLANT BIOLOGY DIVISION   (United States)

^c SOUTHEASTERN OKLAHOMA STATE UNIVERSITY   (United States)

^d Department of Statistics Center for Statistics and Applications in Forensic Evidence Iowa State University 2438 Osborn Dr Ames   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGLYCONE; ALPHA GLUCOSIDASE; AZOXYMETHANE; BETA GLUCOSIDASE; PICEID; RESVERATROL; SYNTHETASE;

ALFALFA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BIOTECHNOLOGY; CANCER PREVENTION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FOOD COMPOSITION; GENETIC ENGINEERING; INTESTINE CRYPT; MOUSE; NONHUMAN; RAT; TRANSGENIC CROP; TRANSGENIC PLANT;

MEDICAGO SATIVA; MUS;

EID: 34447525429     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580701308208     Document Type: Article

References (46)

1. American Cancer Society: http://www.cancer.org; Accessed 10/15/05.
2. World Cancer Research Fund, and American Institute for Cancer Research: Food, Nutrition, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 1997.
3. McCullough ML, Robertson AS, Chao A, et al.: A prospective study of whole grains, fruits, vegetables and colon cancer risk. Cancer Causes Control. 14, 959-70, 2003.
4. Hung H, Joshipura KJ, Jiang R, et al: Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst 96(21), 1577-84, 2004
5. Acamovic T and Brooker JD: Biochemistry of plant secondary metabolites and their effects in animals. Proc Nutr Soc 64, 403-412, 2005.
6. Lambert JD, Hong J, Yang GY, Liao J, Yang CS: Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am J Clin Nutr 81, 284S-91S, 2005.
7. Manach C, Williamson G, Morand C, Scalbert A, and Remesy C: Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81, 230S-42S, 2005.
8. Grusak MA and DellaPenna D: Improving the nutrient composition of plants to enhance nutrition and health. Annu Rev Plant Physiol Plant Miol Biol 50, 133-61, 1999.
9. Muir SR, Collins GJ, Robinson S, et al.: Overexpression of petunia chalcone isomerase in tomato results in fruit containing increased levels of flavonols. Nat Biotechnol 19(5), 470-4, 2001.
10. Fremont L: Biological effects of resveratrol. Life Sci 66(8), 663-73, 2000.
11. Soleas GJ, Diamandis EP, and Goldberg DM: Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal 11, 287-313, 1997.
12. Burns J, Yokota T, Ashihara H, Lean ME, and Crozier A: Plant foods and herbal sources of resveratrol. J Agric Food Chem 50, 3337-3340, 2002.
13. Kopp P: Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur J Endocrinol 138, 619-20, 1998.
14. Jang M, Cai L, Udeani GO, et al.: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-20, 1997.
15. Aziz MH, Kumar R, and Ahmad N: Cancer chemoprevention by resveratrol: In vitro and in vivo studies and the underlying mechanisms. Int J Oncol 23, 17-28, 2003.
16. Hipskind JD and Paiva NL: Constitutive accumulation of a resveratrol-glucoside in transgenic alfalfa increases resistance to Phoma medicaginis. Mol Plant Microbe Interact 13, 551-62, 2000.
17. Takayama T, Miyanishi K, Hayashi T, et al.: Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness. Clin Gastroenterol Hepatol 3, S42-S45, 2005.
18. CIP expression. Carcinogenesis 21(8), 1619-22, 2000.
19. Mori H, Hata K, Yamada Y, Kuno T, and Hara A: Significance and role of early-lesions in experimental colorectal carcinogenesis. Chem Biol Interact 155, 1-9, 2005.
20. Bingham ET: Registration of alfalfa hybrid Regen-SY germplasm for tissue-culture and transformation research. Crop Sci 31, 1098, 1991.
21. Reeves PG, Nielsen FH, and Fahey GC: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformation of the AIN-76A rodent diet. J Nutr 123(11), 1939-51, 1993.
22. King GM: Characteristics of beta-glucosidase activity in intertidal marine sediments. Appl Environ Microbiol 51(2), 373-80, 1986.
23. Bird RP: Observation and quantification of aberrant crypts in the murine colon with a colon carcinogen: preliminary findings. Cancer Lett 37, 147-51, 1987.
24. Fisher RA: Statistical Methods for Research Workers, 14th edition. New York: Hafner Press, 1970.
25. Ibern-Gomez M, Roig-Perez S, Lamuela-Raventos RM, and de la Torre-Boronat MC: Resveratrol and piceid levels in natural and blended peanut. J Agric Food Chem 48, 6352-54, 2000.
26. Ribeiro de Lima MT, Waffo-Teguo P, Teissedre PL, et al.: Determination of stilbenes (trans-astringin, cis- and trans-piceid, and cis- and trans-resveratrol) in Portuguese wines. J Agric Food Chem 47, 2666-2670, 1999.
27. Moreno-Labanda JF, Mallavia R, Perez-Fons L, Lizama V, Saura D, and Micol V: Determination of piceid and resveratrol in Spanish wines deriving from Monastrell (Vitis vinifera L.) grape variety. J Agric Food Chem 52, 5396-5403, 2004.
28. Vitrac X, Bornet A, Vanderlinde R, et al.: Determination of stilbenes (δ-viniferin, trans-astringin, trans-piceid, cis- and trans-resveratrol, ε- viniferin) in Brazillian wines. J Agric Food Chem 53, 5664-5669.
29. Hain R, Reif HJ, Krause E, et al.: Disease resistance results from foreign phytoalexin expression in a novel plant. Nature 361, 153-56, 1993.
30. Stark-Lorenzen P, Nelke B, Hanbler G, Muhlbach HP, Thomzik JE: Transfer of a grapevine stilbene synthase gene to rice (Oryza sativa L). Plant Cell Rep 16, 668-73, 1997.
31. Leckband G and Lorz H: Transformation and expression of a stilbene synthase gene of Vitis vinifera L. in barley and wheat for increased fungal resistance. Theor Appl Genet 96, 1004-1012, 1998.
32. Kobayashi S, Ding CK, Nakamura Y, Nakajima I, and Matsumoto R: Kiwifruits (Actinidia deliciosa) transformed with a Vitis stilbene synthase gene produce piceid (resveratrol-glucoside). Plant Cell Rep 19, 904-910, 2000.
33. Szankowski I, Briviba K, Fleschhut J, Chonherr J, Jacobsen HJ, and Kiesecker H: Transformation of apple (Malus domestica Borkh.) with the stilbene synthase gene from grapevine (Vitis vinifera L.) and a PGIP gene from kiwi (Actinidia deliciosa). Plant Cell Rep 22, 141-49, 2004.
34. Stochmal A, Piacente S, Pizza C, De Riccardis F, Leitz R, and Oleszek W: Alfalfa (Medicago sativa L.) Flavonoids. 1. apigenin and luteolin glycosides from aerial parts. J Agric Food Chem 49, 753-758, 2001a.
35. Stochmal A, Simonet AM, Macias FA, and Oleszek W: Alfalfa (Medicago sativa L.) Flavonoids. 2. Tricin and Chrysoeriol glycosides from aerial parts. J Agric Food Chem 49, 5310-314, 2001b.
36. Orsini F, Pelizzoni F, Verotta L, and Aburjai T: Isolation, synthesis, and antiplatelet aggregation activity of resveratrol-3-O-glucopyranoside and related compounds. J Nat Prod 60, 1082-87, 1997.
37. Kimura Y and Okuda H: Effects of naturally occurring stilbene glucosides from medicinal plants and wine, on tumour growth and lung metastasis in Lewis lung carcinoma-bearing mice. J Pharm Pharmacol 52, 1287-96, 2000.
38. Henry C, Vitrac X, Decendit A, Ennamany R, Krisa S, and Merillon J: Cellular uptake and efflux of trans-piceid and its aglycone trans- resveratrol on the apical membrane of human intestinal Caco-2 cells. J Agric Food Chem 53, 798-803, 2005.
39. Henry-Vitrac C, Desmouliere A, Girard D, Merillon JM, and Krisa S. Transport, deglycosylation and metabolism of trans-piceid by small intestinal epithelial cells. Eur J Nutr 45, 376-382, 2006.
40. Lv C, Zhang L, Wang G, Liu W, Wang C, Jing X, and Liu Y: Determination of piceid in rat plasma and tissue by high-performance liquid chromatography method with UV detector. Biomed Chromotogr 20:1260-6, 2006.
41. Sengottuvelan M, Viswanathan P, and Nalini N: Chemopreventive effect of trans-resveratrol-a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis. Carcinogenesis 27, 1038-46, 2006.
42. Sengottuvelan M, and Nalini N: Dietary supplementation of resveratrol suppresses colonic tumor incidence in 1,2 dimethylhydrazine-treated rats by modulating biotransforming enzymes and ACF development. Br J Nutr 96(1), 145-53, 2006.
43. Schneider Y, Duranton B, Gosse F, et al.: Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human Familial Adenomatous Polyposis. Nutr Cancer 39(1), 102-107, 2001.
44. Sale S, Tunstall RG, Ruparelia KC, et al.: Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4′-tetramethoxystilbene (DMU-212) on adenoma development in the APC mouse and cyclooxygenase-2 in human-derived colon cancer cells. Int J Cancer 115, 194-201, 2005.
45. Corpet DE and Pierre F: Point: from animal models to prevention of colon cancer. Systematic review of chemoprevention in Min mice and choice of model system. Cancer Epidemiol Biomarkers Prev 12(5), 391-400, 2003.
46. Baur JA and Sinclair DA: Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5, 493-506, 2006.